HRT Financial’s AIM ImmunoTech AIM Stock Holding History

HRT Financial’s Portfolio AIM Stock Details AIM Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2026 Q1	$15K	Buy	+26,032	New	+$26.4K	﹤0.01%	3598
2025 Q1	–	Sell	-317	Closed	-$6K	–	3633
2024 Q4	$6K	Sell	317 -31	-9%	-$722	﹤0.01%	2322
2024 Q3	$9K	Buy	+348	New	+$11.6K	﹤0.01%	2236
2023 Q4	–	Sell	-108	Closed	-$4K	–	3395
2023 Q3	$4K	Buy	+108	New	+$6.66K	﹤0.01%	2212
2021 Q1	–	Sell	-117	Closed	-$20K	–	3441
2020 Q4	$20K	Buy	+117	New	+$23.4K	﹤0.01%	1744
2020 Q2	–	Sell	-100	Closed	-$25K	–	1877
2020 Q1	$25K	Buy	+100	New	+$15.7K	﹤0.01%	670

Other funds holding AIM

Virtu Financial New York $2.41B AUM 48.35% 1-Year Est. Return

Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return

XTX Topco George Town, Cayman Islands $5.75B AUM 30.56% 1-Year Est. Return

Jane Street New York $777B AUM 61.18% 1-Year Est. Return

VFT

Vanguard Fiduciary Trust Malvern, Pennsylvania $396B AUM

NewEdge Advisors New Orleans, Louisiana $27.7B AUM 22.98% 1-Year Est. Return

TRCT

Tower Research Capital (TRC) New York $3.85B AUM 32.11% 1-Year Est. Return

Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return

Community Bank Dewitt, New York $840M AUM 22.23% 1-Year Est. Return

Harbour Investments Madison, Wisconsin $6.48B AUM 18.23% 1-Year Est. Return

HRT Financial's AIM Position: Q1 2026 in Review

HRT Financial opened a new position in AIM ImmunoTech (AIM) in Q1 2026: 26,032 shares worth $15K. The stake represents ﹤0.01% of the portfolio and ranks #3598 among its holdings. This is a return to the name: HRT Financial previously reported a position in AIM as recently as Q4 2024.

HRT Financial first reported a position in AIM in Q1 2020 and has held it in 6 quarters since. The position peaked at $25K in Q1 2020. 18 funds tracked by Wall St. Rank hold AIM as of Q1 2026.

HRT Financial held 26,032 shares of AIM ImmunoTech worth $15K as of Q1 2026.
AIM ImmunoTech was a new HRT Financial position in Q1 2026.
AIM ImmunoTech made up ﹤0.01% of HRT Financial's portfolio in Q1 2026, its #3598 holding.
HRT Financial first reported a position in AIM ImmunoTech in Q1 2020 and has held it in 6 quarters since.
HRT Financial's AIM ImmunoTech position peaked at $25K in Q1 2020.
18 funds tracked by Wall St. Rank held AIM ImmunoTech as of Q1 2026.

Based on HRT Financial's 13F filing for Q1 2026, filed 14 May 2026.